These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 18951251

  • 41. Differential changes in functional activity of organic cation transporters in rats with uranyl nitrate-induced acute renal failure.
    Maeng HJ, Shim WS, Ahn SJ, Yu SS, Kim DD, Shim CK, Chung SJ.
    Arch Pharm Res; 2012 Aug; 35(8):1441-8. PubMed ID: 22941487
    [Abstract] [Full Text] [Related]

  • 42. Differential toxicity as a result of apical and basolateral treatment of LLC-PK1 monolayers with S-(1,2,3,4,4-pentachlorobutadienyl)glutathione and N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine.
    Mertens JJ, Weijnen JG, van Doorn WJ, Spenkelink B, Temmink JH, van Bladeren PJ.
    Chem Biol Interact; 1988 Aug; 65(3):283-93. PubMed ID: 3378280
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products.
    Yoshida N, Koizumi M, Adachi I, Kawakami J.
    Food Chem Toxicol; 2006 Dec; 44(12):2033-9. PubMed ID: 16904803
    [Abstract] [Full Text] [Related]

  • 44. Outward transfer of dopamine precursor L-3,4-dihydroxyphenylalanine (L-dopa) by native and human P-glycoprotein in LLC-PK(1) and LLC-GA5 col300 renal cells.
    Soares-Da-Silva P, Serrão MP.
    J Pharmacol Exp Ther; 2000 May; 293(2):697-704. PubMed ID: 10773046
    [Abstract] [Full Text] [Related]

  • 45. Risperidone and paliperidone inhibit p-glycoprotein activity in vitro.
    Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, DeVane CL.
    Neuropsychopharmacology; 2007 Apr; 32(4):757-64. PubMed ID: 16936711
    [Abstract] [Full Text] [Related]

  • 46. Flavonoids with epidermal growth factor-receptor tyrosine kinase inhibitory activity stimulate PEPT1-mediated cefixime uptake into human intestinal epithelial cells.
    Wenzel U, Kuntz S, Daniel H.
    J Pharmacol Exp Ther; 2001 Oct; 299(1):351-7. PubMed ID: 11561098
    [Abstract] [Full Text] [Related]

  • 47. Minor effects of the citrus flavonoids naringin, naringenin and quercetin, on the pharmacokinetics of doxorubicin in rats.
    Park HS, Oh JH, Lee Jh, Lee YJ.
    Pharmazie; 2011 Jun; 66(6):424-9. PubMed ID: 21699081
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2.
    Walle UK, French KL, Walgren RA, Walle T.
    Res Commun Mol Pathol Pharmacol; 1999 Jan; 103(1):45-56. PubMed ID: 10440570
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The transport of ciprofloxacin in cultured kidney epithelial cells LLC-PK1.
    Sasaya M, Oda M, Endo T, Saitoh H, Takada M.
    Biol Pharm Bull; 1997 Aug; 20(8):887-91. PubMed ID: 9300136
    [Abstract] [Full Text] [Related]

  • 52. P-glycoprotein and organic cation secretion by the mammalian kidney.
    Dutt A, Heath LA, Nelson JA.
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1254-60. PubMed ID: 7912280
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Efficiency of transcellular transport and efflux of flavonoids with different glycosidic units from flavonoids of Litsea coreana L. in a MDCK epithelial cell monolayer model.
    Chen Z, Ma T, Huang C, Zhang L, Zhong J, Han J, Hu T, Li J.
    Eur J Pharm Sci; 2014 Mar 12; 53():69-76. PubMed ID: 24365259
    [Abstract] [Full Text] [Related]

  • 55. Transport of procainamide in a kidney epithelial cell line LLC-PK1.
    Takano M, Kato M, Takayama A, Yasuhara M, Inui K, Hori R.
    Biochim Biophys Acta; 1992 Jul 27; 1108(2):133-9. PubMed ID: 1637838
    [Abstract] [Full Text] [Related]

  • 56. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
    Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, Gefroh HA, Devane CL.
    J Pharmacol Exp Ther; 2006 May 27; 317(2):850-7. PubMed ID: 16439618
    [Abstract] [Full Text] [Related]

  • 57. Flavonoid permeability across an in situ model of the blood-brain barrier.
    Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ.
    Free Radic Biol Med; 2004 Mar 01; 36(5):592-604. PubMed ID: 14980703
    [Abstract] [Full Text] [Related]

  • 58. Combined cereal and pulse flavonoids show enhanced bioavailability by downregulating phase II metabolism and ABC membrane transporter function in Caco-2 model.
    Ravisankar S, Agah S, Kim H, Talcott S, Wu C, Awika J.
    Food Chem; 2019 May 01; 279():88-97. PubMed ID: 30611516
    [Abstract] [Full Text] [Related]

  • 59. Effect of bioflavonoids on vincristine transport across blood-brain barrier.
    Mitsunaga Y, Takanaga H, Matsuo H, Naito M, Tsuruo T, Ohtani H, Sawada Y.
    Eur J Pharmacol; 2000 May 03; 395(3):193-201. PubMed ID: 10812049
    [Abstract] [Full Text] [Related]

  • 60. Involvement of Human Multidrug and Toxic Compound Extrusion (MATE) Transporters in Testosterone Transport.
    Goda M, Ikehara M, Sakitani M, Oda K, Ishizawa K, Otsuka M.
    Biol Pharm Bull; 2021 May 03; 44(4):501-506. PubMed ID: 33790101
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.